Lamotrigine sales will expand through 2036, with greater than 99% purity at 82.4% of purity grade demand and tablets at 67.8% of dosage form sales in 2026. The market is estimated at USD 204.3 million in 2026 and is forecast to record a 4.1% CAGR between 2026 and 2036.